Structure

Physi-Chem Properties

Molecular Weight:  512.2
Volume:  519.922
LogP:  5.498
LogD:  2.929
LogS:  -3.617
# Rotatable Bonds:  13
TPSA:  147.43
# H-Bond Aceptor:  9
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.18
Synthetic Accessibility Score:  3.197
Fsp3:  0.429
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.768
MDCK Permeability:  2.5984727471950464e-05
Pgp-inhibitor:  0.135
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.035
20% Bioavailability (F20%):  0.978
30% Bioavailability (F30%):  0.892

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  97.2669448852539%
Volume Distribution (VD):  0.302
Pgp-substrate:  1.1937440633773804%

ADMET: Metabolism

CYP1A2-inhibitor:  0.262
CYP1A2-substrate:  0.128
CYP2C19-inhibitor:  0.131
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.785
CYP2C9-substrate:  0.654
CYP2D6-inhibitor:  0.302
CYP2D6-substrate:  0.131
CYP3A4-inhibitor:  0.163
CYP3A4-substrate:  0.037

ADMET: Excretion

Clearance (CL):  6.31
Half-life (T1/2):  0.918

ADMET: Toxicity

hERG Blockers:  0.029
Human Hepatotoxicity (H-HT):  0.227
Drug-inuced Liver Injury (DILI):  0.978
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.567
Maximum Recommended Daily Dose:  0.836
Skin Sensitization:  0.832
Carcinogencity:  0.019
Eye Corrosion:  0.003
Eye Irritation:  0.073
Respiratory Toxicity:  0.881

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC284007

Natural Product ID:  NPC284007
Common Name*:   Alpha-Alectoronic Acid
IUPAC Name:   3,9-dihydroxy-6-oxo-1,7-bis(2-oxoheptyl)benzo[b][1,4]benzodioxepine-2-carboxylic acid
Synonyms:   Alpha-Alectoronic Acid
Standard InCHIKey:  ZDIOCINAHISORH-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C28H32O9/c1-3-5-7-9-17(29)11-16-12-19(31)14-22-24(16)28(35)37-23-15-21(32)25(27(33)34)20(26(23)36-22)13-18(30)10-8-6-4-2/h12,14-15,31-32H,3-11,13H2,1-2H3,(H,33,34)
SMILES:  CCCCCC(=O)Cc1cc(cc2c1C(=O)Oc1cc(c(c(CC(=O)CCCCC)c1O2)C(=O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL426543
PubChem CID:   15558610
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0001645] Depsides and depsidones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10332 Garcinia atroviridis Species Clusiaceae Eukaryota roots n.a. n.a. PMID[11473441]
NPO16337 Ochrolechia parella Species Ochrolechiaceae Eukaryota n.a. n.a. n.a. PMID[17256903]
NPO12221 Acacia saligna Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25183120]
NPO27306 Sterculia urens Species Malvaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10332 Garcinia atroviridis Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12221 Acacia saligna Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16337 Ochrolechia parella Species Ochrolechiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13194 Gentiana purpurea Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT319 Cell Line B16 Mus musculus IC50 = 10300.0 nM PMID[478417]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC284007 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC267153
0.9935 High Similarity NPC93739
0.9808 High Similarity NPC8070
0.9618 High Similarity NPC300984
0.9615 High Similarity NPC303565
0.9545 High Similarity NPC471800
0.9371 High Similarity NPC474350
0.9363 High Similarity NPC238381
0.9321 High Similarity NPC20543
0.9321 High Similarity NPC246716
0.9321 High Similarity NPC239440
0.9268 High Similarity NPC139350
0.9259 High Similarity NPC26568
0.9255 High Similarity NPC20216
0.925 High Similarity NPC156082
0.9236 High Similarity NPC54928
0.9221 High Similarity NPC6923
0.9207 High Similarity NPC181523
0.9202 High Similarity NPC1827
0.9202 High Similarity NPC17219
0.9202 High Similarity NPC10576
0.9198 High Similarity NPC272485
0.9198 High Similarity NPC292788
0.9193 High Similarity NPC112981
0.9161 High Similarity NPC60413
0.9152 High Similarity NPC289147
0.9141 High Similarity NPC49487
0.9141 High Similarity NPC99613
0.9119 High Similarity NPC83763
0.9119 High Similarity NPC168616
0.9114 High Similarity NPC274730
0.9102 High Similarity NPC113446
0.9085 High Similarity NPC124470
0.9085 High Similarity NPC109827
0.9062 High Similarity NPC320359
0.9062 High Similarity NPC475886
0.9062 High Similarity NPC200594
0.9062 High Similarity NPC474287
0.9057 High Similarity NPC241904
0.9057 High Similarity NPC165977
0.9057 High Similarity NPC217677
0.9057 High Similarity NPC300727
0.9045 High Similarity NPC289968
0.903 High Similarity NPC158226
0.9018 High Similarity NPC29160
0.9006 High Similarity NPC474186
0.9006 High Similarity NPC278052
0.9006 High Similarity NPC474351
0.9006 High Similarity NPC474187
0.9006 High Similarity NPC40491
0.9006 High Similarity NPC475883
0.9 High Similarity NPC476242
0.9 High Similarity NPC100123
0.8987 High Similarity NPC475895
0.8987 High Similarity NPC89474
0.8981 High Similarity NPC474663
0.8963 High Similarity NPC234331
0.8961 High Similarity NPC29577
0.8951 High Similarity NPC8300
0.8944 High Similarity NPC14353
0.8944 High Similarity NPC56085
0.8944 High Similarity NPC200746
0.8944 High Similarity NPC228785
0.8938 High Similarity NPC236796
0.8931 High Similarity NPC38898
0.8917 High Similarity NPC29056
0.8909 High Similarity NPC165979
0.8909 High Similarity NPC163130
0.8903 High Similarity NPC237208
0.8896 High Similarity NPC7483
0.8896 High Similarity NPC234004
0.8896 High Similarity NPC236132
0.8889 High Similarity NPC61010
0.8889 High Similarity NPC66288
0.8876 High Similarity NPC240887
0.8876 High Similarity NPC470091
0.8876 High Similarity NPC329161
0.8875 High Similarity NPC142339
0.8875 High Similarity NPC472456
0.8868 High Similarity NPC250822
0.8868 High Similarity NPC276409
0.8868 High Similarity NPC280937
0.8868 High Similarity NPC75279
0.8861 High Similarity NPC202157
0.8861 High Similarity NPC208043
0.8861 High Similarity NPC198615
0.8861 High Similarity NPC226973
0.8861 High Similarity NPC117579
0.8854 High Similarity NPC328119
0.8841 High Similarity NPC130920
0.8841 High Similarity NPC39306
0.8841 High Similarity NPC85057
0.8839 High Similarity NPC134621
0.8834 High Similarity NPC229632
0.8834 High Similarity NPC108767
0.8834 High Similarity NPC25152
0.8827 High Similarity NPC119224
0.8827 High Similarity NPC143050
0.8827 High Similarity NPC139036
0.882 High Similarity NPC181960
0.882 High Similarity NPC469584
0.882 High Similarity NPC108456
0.8812 High Similarity NPC163780
0.8812 High Similarity NPC183597
0.8812 High Similarity NPC37392
0.8812 High Similarity NPC50715
0.8812 High Similarity NPC201136
0.8812 High Similarity NPC20541
0.8812 High Similarity NPC92659
0.8812 High Similarity NPC128863
0.8812 High Similarity NPC146165
0.8812 High Similarity NPC227325
0.8812 High Similarity NPC196439
0.8812 High Similarity NPC472909
0.8812 High Similarity NPC2476
0.8812 High Similarity NPC167815
0.8812 High Similarity NPC208197
0.8812 High Similarity NPC138360
0.8812 High Similarity NPC280339
0.8812 High Similarity NPC4455
0.8797 High Similarity NPC307780
0.8797 High Similarity NPC306821
0.8797 High Similarity NPC309979
0.8797 High Similarity NPC151473
0.8797 High Similarity NPC179183
0.8788 High Similarity NPC39091
0.878 High Similarity NPC475985
0.878 High Similarity NPC197168
0.878 High Similarity NPC133065
0.878 High Similarity NPC23298
0.878 High Similarity NPC270837
0.878 High Similarity NPC220313
0.878 High Similarity NPC248638
0.878 High Similarity NPC189473
0.878 High Similarity NPC152659
0.878 High Similarity NPC236521
0.8774 High Similarity NPC95123
0.8774 High Similarity NPC66404
0.8773 High Similarity NPC258331
0.8766 High Similarity NPC105648
0.8765 High Similarity NPC474290
0.8765 High Similarity NPC329091
0.8758 High Similarity NPC474520
0.8758 High Similarity NPC68093
0.8758 High Similarity NPC472907
0.8758 High Similarity NPC191146
0.8758 High Similarity NPC178854
0.8758 High Similarity NPC138243
0.8758 High Similarity NPC257277
0.875 High Similarity NPC145379
0.875 High Similarity NPC47781
0.875 High Similarity NPC274327
0.875 High Similarity NPC186507
0.875 High Similarity NPC176775
0.875 High Similarity NPC246204
0.875 High Similarity NPC183878
0.875 High Similarity NPC69394
0.875 High Similarity NPC231018
0.875 High Similarity NPC22519
0.875 High Similarity NPC86485
0.875 High Similarity NPC255350
0.875 High Similarity NPC160951
0.875 High Similarity NPC472915
0.8742 High Similarity NPC308451
0.8742 High Similarity NPC133856
0.8742 High Similarity NPC204350
0.8742 High Similarity NPC149614
0.8734 High Similarity NPC474648
0.8734 High Similarity NPC285527
0.8734 High Similarity NPC106334
0.8727 High Similarity NPC472450
0.8727 High Similarity NPC326520
0.8727 High Similarity NPC275780
0.8727 High Similarity NPC25361
0.8727 High Similarity NPC239752
0.8726 High Similarity NPC93034
0.8726 High Similarity NPC119660
0.8726 High Similarity NPC62536
0.8726 High Similarity NPC12305
0.8726 High Similarity NPC33265
0.872 High Similarity NPC52204
0.872 High Similarity NPC294965
0.8718 High Similarity NPC312789
0.8712 High Similarity NPC299436
0.8712 High Similarity NPC235018
0.8712 High Similarity NPC45146
0.8712 High Similarity NPC47623
0.8704 High Similarity NPC476981
0.8704 High Similarity NPC475267
0.8704 High Similarity NPC472910
0.8704 High Similarity NPC93376
0.8704 High Similarity NPC472963
0.8704 High Similarity NPC245758
0.8704 High Similarity NPC262286
0.8704 High Similarity NPC48208
0.8704 High Similarity NPC235215
0.8704 High Similarity NPC7973
0.8704 High Similarity NPC472438
0.8704 High Similarity NPC162869
0.8704 High Similarity NPC227192

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC284007 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD2801 Approved
0.8675 High Similarity NPD7473 Discontinued
0.8606 High Similarity NPD6232 Discontinued
0.8519 High Similarity NPD1465 Phase 2
0.8466 Intermediate Similarity NPD3817 Phase 2
0.8457 Intermediate Similarity NPD1934 Approved
0.8405 Intermediate Similarity NPD7819 Suspended
0.8353 Intermediate Similarity NPD5844 Phase 1
0.8303 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD3882 Suspended
0.8302 Intermediate Similarity NPD1511 Approved
0.8293 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8266 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8199 Intermediate Similarity NPD1512 Approved
0.8198 Intermediate Similarity NPD7074 Phase 3
0.8187 Intermediate Similarity NPD3818 Discontinued
0.8176 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD6166 Phase 2
0.816 Intermediate Similarity NPD3226 Approved
0.8155 Intermediate Similarity NPD5494 Approved
0.8144 Intermediate Similarity NPD7075 Discontinued
0.814 Intermediate Similarity NPD7054 Approved
0.8092 Intermediate Similarity NPD7472 Approved
0.8061 Intermediate Similarity NPD7411 Suspended
0.8036 Intermediate Similarity NPD3749 Approved
0.8025 Intermediate Similarity NPD2532 Approved
0.8025 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD2534 Approved
0.8025 Intermediate Similarity NPD2533 Approved
0.8024 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3750 Approved
0.7964 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD6799 Approved
0.7955 Intermediate Similarity NPD7808 Phase 3
0.7949 Intermediate Similarity NPD447 Suspended
0.7943 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD5402 Approved
0.7898 Intermediate Similarity NPD7251 Discontinued
0.7895 Intermediate Similarity NPD6959 Discontinued
0.7895 Intermediate Similarity NPD1247 Approved
0.7892 Intermediate Similarity NPD6599 Discontinued
0.7889 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2935 Discontinued
0.7861 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD6797 Phase 2
0.7824 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD3926 Phase 2
0.7799 Intermediate Similarity NPD2799 Discontinued
0.7798 Intermediate Similarity NPD6801 Discontinued
0.7784 Intermediate Similarity NPD4380 Phase 2
0.7778 Intermediate Similarity NPD919 Approved
0.7771 Intermediate Similarity NPD1240 Approved
0.7764 Intermediate Similarity NPD1549 Phase 2
0.7716 Intermediate Similarity NPD2800 Approved
0.7711 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7701 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD37 Approved
0.7688 Intermediate Similarity NPD7199 Phase 2
0.7688 Intermediate Similarity NPD1510 Phase 2
0.7688 Intermediate Similarity NPD3748 Approved
0.7674 Intermediate Similarity NPD6234 Discontinued
0.7673 Intermediate Similarity NPD1607 Approved
0.7661 Intermediate Similarity NPD4966 Approved
0.7661 Intermediate Similarity NPD7768 Phase 2
0.7661 Intermediate Similarity NPD4965 Approved
0.7661 Intermediate Similarity NPD4967 Phase 2
0.7658 Intermediate Similarity NPD943 Approved
0.7643 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD2796 Approved
0.7627 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD230 Phase 1
0.7609 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD1243 Approved
0.76 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD2346 Discontinued
0.7578 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD3268 Approved
0.7531 Intermediate Similarity NPD6100 Approved
0.7531 Intermediate Similarity NPD1551 Phase 2
0.7531 Intermediate Similarity NPD6099 Approved
0.7527 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5403 Approved
0.75 Intermediate Similarity NPD920 Approved
0.75 Intermediate Similarity NPD6559 Discontinued
0.7472 Intermediate Similarity NPD7228 Approved
0.7469 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD4628 Phase 3
0.7455 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD5953 Discontinued
0.7443 Intermediate Similarity NPD5710 Approved
0.7443 Intermediate Similarity NPD5711 Approved
0.7436 Intermediate Similarity NPD1203 Approved
0.743 Intermediate Similarity NPD7286 Phase 2
0.7425 Intermediate Similarity NPD7390 Discontinued
0.7425 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD6832 Phase 2
0.7391 Intermediate Similarity NPD8434 Phase 2
0.7381 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD5401 Approved
0.7378 Intermediate Similarity NPD2344 Approved
0.7353 Intermediate Similarity NPD1653 Approved
0.7346 Intermediate Similarity NPD6651 Approved
0.7342 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD8312 Approved
0.7322 Intermediate Similarity NPD8313 Approved
0.7312 Intermediate Similarity NPD2313 Discontinued
0.7303 Intermediate Similarity NPD5242 Approved
0.7296 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD1933 Approved
0.7278 Intermediate Similarity NPD3751 Discontinued
0.7262 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD3787 Discontinued
0.7247 Intermediate Similarity NPD7229 Phase 3
0.7244 Intermediate Similarity NPD9717 Approved
0.7244 Intermediate Similarity NPD1608 Approved
0.7235 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7783 Phase 2
0.7216 Intermediate Similarity NPD7435 Discontinued
0.7215 Intermediate Similarity NPD2797 Approved
0.7215 Intermediate Similarity NPD3267 Approved
0.7215 Intermediate Similarity NPD3266 Approved
0.7208 Intermediate Similarity NPD8151 Discontinued
0.7204 Intermediate Similarity NPD8150 Discontinued
0.7202 Intermediate Similarity NPD2309 Approved
0.7202 Intermediate Similarity NPD6190 Approved
0.72 Intermediate Similarity NPD5353 Approved
0.7179 Intermediate Similarity NPD422 Phase 1
0.7178 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD2403 Approved
0.7143 Intermediate Similarity NPD3027 Phase 3
0.7134 Intermediate Similarity NPD9269 Phase 2
0.7128 Intermediate Similarity NPD4287 Approved
0.7126 Intermediate Similarity NPD6386 Approved
0.7126 Intermediate Similarity NPD6385 Approved
0.712 Intermediate Similarity NPD7685 Pre-registration
0.712 Intermediate Similarity NPD7240 Approved
0.7117 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD1613 Approved
0.7102 Intermediate Similarity NPD4288 Approved
0.7099 Intermediate Similarity NPD3764 Approved
0.7099 Intermediate Similarity NPD411 Approved
0.7097 Intermediate Similarity NPD9268 Approved
0.7095 Intermediate Similarity NPD8127 Discontinued
0.7066 Intermediate Similarity NPD1471 Phase 3
0.7062 Intermediate Similarity NPD6776 Approved
0.7062 Intermediate Similarity NPD6780 Approved
0.7062 Intermediate Similarity NPD6778 Approved
0.7062 Intermediate Similarity NPD6782 Approved
0.7062 Intermediate Similarity NPD6781 Approved
0.7062 Intermediate Similarity NPD6777 Approved
0.7062 Intermediate Similarity NPD6779 Approved
0.7051 Intermediate Similarity NPD17 Approved
0.7048 Intermediate Similarity NPD4308 Phase 3
0.7044 Intermediate Similarity NPD3225 Approved
0.7041 Intermediate Similarity NPD7698 Approved
0.7041 Intermediate Similarity NPD7696 Phase 3
0.7041 Intermediate Similarity NPD7697 Approved
0.7012 Intermediate Similarity NPD4060 Phase 1
0.7006 Intermediate Similarity NPD5408 Approved
0.7006 Intermediate Similarity NPD5404 Approved
0.7006 Intermediate Similarity NPD5406 Approved
0.7006 Intermediate Similarity NPD5405 Approved
0.7005 Intermediate Similarity NPD7871 Phase 2
0.7005 Intermediate Similarity NPD7870 Phase 2
0.7 Intermediate Similarity NPD7874 Approved
0.7 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.6995 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6994 Remote Similarity NPD1296 Phase 2
0.6994 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6989 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7549 Discontinued
0.6977 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6977 Remote Similarity NPD7422 Clinical (unspecified phase)
0.697 Remote Similarity NPD6355 Discontinued
0.6957 Remote Similarity NPD2798 Approved
0.6946 Remote Similarity NPD7033 Discontinued
0.6933 Remote Similarity NPD4625 Phase 3
0.6932 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6923 Remote Similarity NPD8285 Discontinued
0.6918 Remote Similarity NPD1481 Phase 2
0.6915 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6914 Remote Similarity NPD9494 Approved
0.6914 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6914 Remote Similarity NPD7458 Discontinued
0.6905 Remote Similarity NPD4476 Approved
0.6905 Remote Similarity NPD4477 Approved
0.6904 Remote Similarity NPD6823 Phase 2
0.6902 Remote Similarity NPD7893 Clinical (unspecified phase)
0.69 Remote Similarity NPD7701 Phase 2
0.6894 Remote Similarity NPD1470 Approved
0.6875 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4908 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data